Page 66 - 2018 Annual Report Taiwan Intellectual Property Office

.
According to the definition of regenerative medicine in different countries and the abstract of Program Project for Regenerative Medicine launched by the Ministry of Science and Technology, the field of regenerative medicine in this report was categorized into four domains: stem cell, tissue engineering, cell therapy, and gene therapy. Based on the domains of the technology, TIPO conducted a patent trend analysis on the patent applications filed in Taiwan, the United States, Japan, Europe, and mainland China between 2000 and 2017. Furthermore, TIPO collected and compared the patent laws, regulations and court decisions related to regenerative medicine in different countries, and provided suggestions on the protection of regenerative medicine inventions.
This report also focused on the development trend of regenerative medicine inventions in different countries in recent years, and analyzed ethical issues, patent eligibility and other complicated issues as well as patent application strategy. This report was aimed at enhancing the quality of regenerative medicine patent applications in Taiwan, and helping domestic industries to build global patent portfolios. This report will be open to the public in 2019 on TIPO’s website.
In this report, we chose the Derwent Innovation as the data source for patent trend analysis. As Stem Cell is the core technological for the field of regenerative medicine, the analysis of stem cell-related patents was shown below. Between 2000 and 2017, 12,183 stem cell-related patent applications were filed in the Unites States, accounting for the majority of total applications, followed by Europe (5,493 cases), mainland China (4,976 cases), and Japan (4,427 cases). There were 354 applications in Taiwan.
Stem cell-related patent applications filed in foreign patent offices from 2000 to 2017
Patent Trend and Patentability Criteria of Regenerative Medicine in Taiwan and Major Countries
1500
1400
1300
1200
1100
1000
900
800
700
600
500
400
300
200
100
USPTO
EPO JPO
CNIPA TIPO
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Note: The patent applications that had been published were calculated in the analysis of 2017. The numbers do not stand for overall applications.
64
V IPR CREATION AND USE